Dalbavancin

• Target:

  Antibiotic|||Antibacterial

• Related Pathways:

  Microbiology/Virology

• Purity:

  0.9909

• Bioactivity:

  Dalbavancin (BI-397), a novel second-generation lipoglycopeptide antibiotic, possesses in vitro activity against a variety of Gram-positive pathogens including methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-resistant Staphylococcus epidermidis (MRSE), Dalbavancin inhibits Staphylococcus aureus and Bacillus anthracis with MIC90s of 0.06 ?g/mL and 0.25 ?g/mL, respectively

• Smiles:

  [H][C@@]1 (Oc2c3Oc4ccc (C[C@@]5 ([H]) NC (=O) [C@H] (NC) c6ccc (O) c (Oc7cc (O) c (Cl) c (c7) [C@] ([H]) (NC5=O) C (=O) N[C@]5 ([H]) c (c3) cc2Oc2ccc (cc2Cl) [C@@H] (O) [C@]2 ([H]) NC (=O) [C@] ([H]) (NC5=O) c3ccc (O) c (c3) -c3c (O[C@H]5O[C@H] (CO) [C@@H] (O) [C@H] (O) [C@@H]5O) cc (O) cc3[C@H] (NC2=O) C (=O) NCCCN (C) C) c6) cc4) O[C@@H] ([C@@H] (O) [C@H] (O) [C@H]1NC (=O) CCCCCCCCC (C) C) C (O) =O

• Molecular Formula:

  C88H100Cl2N10O28

• Molecular Weight:

  1816.71

• Shipping Conditions:

  Cool pack

• Storage Temperature:

  -20°C

• CAS Number:

  171500-79-1